Categories: News

Wave Life Sciences First Quarter 2023 Financial Results Scheduled for May 3, 2023

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, will host a live webcast and conference call at 8:30 a.m. ET on Wednesday, May 3, 2023, to review the company’s first quarter 2023 financial results and provide business updates.

The webcast and conference call may be accessed by visiting “Investor Events” on the investor relations section of the Wave Life Sciences website: ir.wavelifesciences.com/events-and-presentations.

Analysts planning to participate during the Q&A portion of the live call can join the conference call at the following audio conferencing link: available here. Once registered, participants will receive the dial-in information.

Following the live event, an archived version of the webcast will be available on the Wave Life Sciences website.

About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.

Investor Contact:
Kate Rausch
617-949-4827
InvestorRelations@wavelifesci.com

Media Contact:
Alicia Suter
617-949-4817
asuter@wavelifesci.com

Staff

Recent Posts

FendX Engages Branding Expert to Support Branding and Marketing for Its Planned Eco-Friendly Sponge Products

Oakville, Ontario--(Newsfile Corp. - June 11, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF)…

7 minutes ago

London College of Contemporary Arts Launches Free Mental Health and Wellness Support for Students and Staff

Global mental health and wellness solution leader Uwill accelerates international expansion with fifth UK partnership…

7 minutes ago

P2P Group Increases Biometric Detection Range by 166%–Transforming Security, Defence and Aged Care

(CSE: PPB / FSE: 3QG / US: PPBGF)investor@p2p-group.com Highlights: Opens new markets in border control,…

7 minutes ago

Strategikon Pharma Secures Growth Loan to Expand Sales and Client Support Teams Amid Rising Demand

Company-friendly debt solution will support expansion of the rapidly-growing innovative software company SAN FRANCISCO, June…

6 hours ago

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

SAN DIEGO, June 10, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), aligned with its commitments…

12 hours ago

Applied Medical Technology, Inc. Unveils Redesigned Mobile App Aligned with Recent Website Refresh

BRECKSVILLE, Ohio., June 10, 2025 /PRNewswire/ -- Applied Medical Technology, Inc. (AMT), a leader in innovative…

12 hours ago